DK474688A - Praeparat til bekaempelse af tumor eller kraeftceller - Google Patents

Praeparat til bekaempelse af tumor eller kraeftceller

Info

Publication number
DK474688A
DK474688A DK474688A DK474688A DK474688A DK 474688 A DK474688 A DK 474688A DK 474688 A DK474688 A DK 474688A DK 474688 A DK474688 A DK 474688A DK 474688 A DK474688 A DK 474688A
Authority
DK
Denmark
Prior art keywords
cell
tumor
administration
radiation
compound
Prior art date
Application number
DK474688A
Other languages
Danish (da)
English (en)
Other versions
DK474688D0 (da
Inventor
Ronald W Pero
Original Assignee
Oxi Gene Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxi Gene Inc filed Critical Oxi Gene Inc
Publication of DK474688D0 publication Critical patent/DK474688D0/da
Publication of DK474688A publication Critical patent/DK474688A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK474688A 1987-08-25 1988-08-25 Praeparat til bekaempelse af tumor eller kraeftceller DK474688A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8947787A 1987-08-25 1987-08-25

Publications (2)

Publication Number Publication Date
DK474688D0 DK474688D0 (da) 1988-08-25
DK474688A true DK474688A (da) 1989-02-26

Family

ID=22217866

Family Applications (1)

Application Number Title Priority Date Filing Date
DK474688A DK474688A (da) 1987-08-25 1988-08-25 Praeparat til bekaempelse af tumor eller kraeftceller

Country Status (13)

Country Link
US (1) US5340565A (de)
EP (1) EP0305008B1 (de)
JP (1) JP2767590B2 (de)
AT (1) ATE106749T1 (de)
AU (1) AU622118B2 (de)
CA (1) CA1336409C (de)
DE (1) DE3850007T2 (de)
DK (1) DK474688A (de)
ES (1) ES2056902T3 (de)
IE (1) IE63858B1 (de)
IL (1) IL87525A (de)
RU (1) RU2080115C1 (de)
ZA (1) ZA885929B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1247937B (it) * 1991-05-16 1995-01-05 Ist Naz Ric Sul Cancro Associazione farmaceutica ad attivita' antineoplastica
IT1252126B (it) * 1991-11-22 1995-06-05 Ist Naz Ric Sul Cancro Triamino platino complessi e loro metodo di sintesi
GB9404485D0 (en) 1994-03-09 1994-04-20 Cancer Res Campaign Tech Benzamide analogues
US5624902A (en) * 1995-06-07 1997-04-29 Torrey Pines Institute For Molecular Studies Peptide inhibitors of calmodulin
US6056960A (en) * 1995-06-07 2000-05-02 Kaslow; Harvey R. Compositions exhibiting ADP-ribosyltransferase activity and methods for the preparation and use thereof
US6028111A (en) * 1996-03-08 2000-02-22 Oxigene, Inc. Compositions and use of benzamides and nicotinamides as anti-inflammatory agents
US6713517B1 (en) * 1996-03-08 2004-03-30 Oxigene, Inc. Use of aryl N-substituted carboxamides directly and as radio-and chemosensitizers for killing tumor and cancer cells and novel compounds for such use
AU6165798A (en) * 1997-02-18 1998-09-08 Bridge Pharma, Inc. Non-sedating histamine antagonist compounds, compositions and methods of use thereof
US6074626A (en) * 1998-03-20 2000-06-13 Molecular Radiation Management, Inc. Radioactive cisplatin in the treatment of cancer
DE19920936A1 (de) * 1999-05-07 2000-11-09 Basf Ag Heterozyklisch substituierte Benzimidazole, deren Herstellung und Anwendung
AU775373B2 (en) 1999-10-01 2004-07-29 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
US6573050B1 (en) 1999-10-29 2003-06-03 Sunnybrook & Women's College Health Sciences Centre Treatment, diagnosis and evaluation of anti-cancer therapy resistance in melanoma
US6448288B1 (en) * 2000-05-17 2002-09-10 University Of Massachusetts Cannabinoid drugs
EP1345917A1 (de) * 2000-12-19 2003-09-24 Ucb, S.A. 2-(2-(4-((2r)-2-methyl-3-(10h-phenothiazin-10-yl)propyl)-1-piperazinyl)-ethoxy)ethanol, ein verfahren zur herstellung desselben,besagte verbindung beinhaltende pharmazeutische zusammensetzungen,sowie die therapeutische anwendung derselben
FR2825279B1 (fr) * 2001-06-01 2005-04-08 Molecular Engines Lab Medicament utile dans le traitement du cancer
US7547716B2 (en) 2001-06-08 2009-06-16 Institute Of Medicinal Molecular Design, Inc. Sulfonamide derivatives
WO2010025135A2 (en) * 2008-08-28 2010-03-04 Osteogenex Inc. Trimeprazine and ethopropazine derivatives for promoting bone growth
FR2970965A1 (fr) * 2011-01-31 2012-08-03 Centre Nat Rech Scient Composes anti-angiogeniques, compositions pharmaceutiques les comprenant, et leur utilisation
EP2825173B1 (de) 2012-03-16 2018-10-10 Children's Medical Center Corporation Calmodulin-hemmer zur behandlung von ribosomalen erkrankungen und ribosomapathien

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4536386B1 (en) * 1981-01-26 1995-03-07 Robins Co Inc A H Method of controlling emesis caused by cisplatin in cancer chemotherapy
US5081153A (en) * 1984-05-17 1992-01-14 Beecham Group P.L.C. Sterile parenteral composition

Also Published As

Publication number Publication date
RU2080115C1 (ru) 1997-05-27
ES2056902T3 (es) 1994-10-16
CA1336409C (en) 1995-07-25
IE882487L (en) 1989-02-25
EP0305008A2 (de) 1989-03-01
DE3850007D1 (de) 1994-07-14
JP2767590B2 (ja) 1998-06-18
US5340565A (en) 1994-08-23
AU622118B2 (en) 1992-04-02
AU2150888A (en) 1989-03-02
IL87525A0 (en) 1989-01-31
ZA885929B (en) 1989-04-26
EP0305008B1 (de) 1994-06-08
IE63858B1 (en) 1995-06-14
JPH0196122A (ja) 1989-04-14
DK474688D0 (da) 1988-08-25
DE3850007T2 (de) 1994-09-22
EP0305008A3 (en) 1990-05-16
IL87525A (en) 1994-05-30
ATE106749T1 (de) 1994-06-15

Similar Documents

Publication Publication Date Title
DK474688A (da) Praeparat til bekaempelse af tumor eller kraeftceller
Ghezzi et al. Enhanced xanthine oxidase activity in mice treated with interferon and interferon inducers
Hansen et al. The variability of individual tolerance to methotrexate in cancer patients
EA200500893A1 (ru) Трициклические соединения, представляющие собой ингибиторы протеинкиназ, для увеличения эффективности противоопухолевых агентов и лучевой терапии
ATE33556T1 (de) Adenosinderivate enthaltende pharmazeutische zusammensetzung fuer behandlung von tumoren.
ES2037082T3 (es) Una composicion para la liberacion controlada de un farmaco.
SE8504945L (sv) Farmaceutiska kompositioner innehallande antracyklinglykosider
SE8702642L (sv) Lokalt anvendbara, farmaceutiska beredningar
SE8402098L (sv) Perfluorkarbonemulsion, framstellning derav samt dess anvendning i terapi
Griswold Jr et al. ALTERED SENSITIVITY OF A HAMSTER PLASMACYTOMA TO CYTOSINE ARABINOSIDE (NSC-63878) 1.2. 3
SE8303003D0 (sv) Medel for att oka antitumorverkan hos antitumormedel
CO4940430A1 (es) Compuestos policiclicos que contienen estaurosporina hidrogenada con propiedades farmacologicas convenientes y un efecto inhibidor sobre el crecimiento de las celulas tumorales
TR200100021T2 (tr) Kandaki yağ değerlerini etkileyen en az bir etki maddesine sahip bileşim
AR021693A1 (es) 4,5-AZOLO-OXINDOLES,COMPOSICIoN FARMACEUTICA QUE LOS CONTIENE,USO DE LOS MISMOS EN LA PREPARACIoN DE MEDICAMENTOS,Y COMPUESTOS INTERMEDIARIOS UTILES EN LA SíNTESIS DE LOS MISMOS.
Greer et al. The immunological impact of nuclear warfare
Grindey et al. Modulation versus Rescue of Antimetabolite Toxicity by Salvage Metabolites Administered by Continuous Infusion1
Baguley et al. A carbamate analogue of amsacrine with activity against non-cycling cells stimulates topoisomerase II cleavage at DNA sites distinct from those of amsacrine
Valeriote et al. Dose and interval relationship for the interaction of WR-2721 and nitrogen mustard with normal and malignant cells
Freedman et al. Cyclic AMP maintenance of rabbit reticulocyte haem and protein synthesis in the presence of ethanol and benzene
Santelli et al. Cytotoxic effect of 5-fluorouracil plus cyclophosphamide against transplantable leukemias
Bhuyana et al. Suicidal Death of Human Erythrocytes Following Exposure to Pentostatin
SU1563696A1 (ru) Радиопротектор "Диэтон
Kjellén et al. Effect of hyperthermia and/or nicotinamide on the radiation response of a C3H mammary carcinoma
PT90039A (pt) Processo de preparacao de oxidos de 1,2,4-benzotriazina e de composicoes faemaceuticas que os contem
KR940703656A (ko) 에이즈 바이러스 감염 저해용 조성물

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment